Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 5318-5325, July 1, 2008. doi: 10.1158/0008-5472.CAN-08-0601
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Magda, D.
Right arrow Articles by Sessler, J. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magda, D.
Right arrow Articles by Sessler, J. L.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Synthesis and Anticancer Properties of Water-Soluble Zinc Ionophores

Darren Magda1, Philip Lecane1, Zhong Wang1, Weilin Hu1, Patricia Thiemann1, Xuan Ma1, Patricia K. Dranchak2, Xiaoming Wang2, Vincent Lynch3, Wenhao Wei3, Viktor Csokai3, Joseph G. Hacia2 and Jonathan L. Sessler3

1 Pharmacyclics, Inc., Sunnyvale, California; 2 Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, California; and 3 Department of Chemistry and Biochemistry, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas

Requests for reprints: Darren Magda, Pharmacyclics, Inc., 995 E. Arques Avenue, Sunnyvale, CA 94085. Phone: 408-774-3318; Fax: 408-774-0340; E-mail: dmagda{at}pcyc.com.

Key Words: pyrithione • zinc • thioredoxin reductase • motexafin gadolinium

Several water-solubilized versions of the zinc ionophore 1-hydroxypyridine-2-thione (ZnHPT), synthesized as part of the present study, have been found both to increase the intracellular concentrations of free zinc and to produce an antiproliferative activity in exponential phase A549 human lung cancer cultures. Gene expression profiles of A549 cultures treated with one of these water-soluble zinc ionophores, PCI-5002, reveal the activation of stress response pathways under the control of metal-responsive transcription factor 1 (MTF-1), hypoxia-inducible transcription factor 1 (HIF-1), and heat shock transcription factors. Additional oxidative stress response and apoptotic pathways were activated in cultures grown in zinc-supplemented media. We also show that these water-soluble zinc ionophores can be given to mice at 100 µmol/kg (300 µmol/m2) with no observable toxicity and inhibit the growth of A549 lung and PC3 prostate cancer cells grown in xenograft models. Gene expression profiles of tumor specimens harvested from mice 4 h after treatment confirmed the in vivo activation of MTF-1–responsive genes. Overall, we propose that water-solubilized zinc ionophores represent a potential new class of anticancer agents. [Cancer Res 2008;68(13):5318–25]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.